SOURCE: OTC Report

January 24, 2006 08:00 ET

TewMillion.com Features iMagin and SiteWorks Inc., Announces The OTC Report

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the OTC Report.

LAKE HARMONY, PA -- (MARKET WIRE) -- January 24, 2006 -- The OTC Report recommends iMagin (OTC BB: IMGM) and SiteWorks Inc. (OTC BB: SWKJ). iMagin Diagnostic Centres, Inc. has developed a unique strategy for the development of medical diagnostic molecular imaging facilities globally commencing in Canada. The Company is, through its affiliates, the first to bring private-for-pay PET scans to the British Columbia and Ontario markets and plans to participate in bringing PET and molecular imaging technology to all Canadian provinces. As a parallel strategy, iMAGIN plans to pursue the development of molecular imaging and radiopharmaceutical manufacturing and/or distribution facilities in certain global markets.

SiteWorks Inc. is a multi-disciplined real estate and development services organization engaged primarily in the customer satisfaction business. Management and Staff are dedicated to the belief that the expectations of the customer must always be exceeded.

For more information, go to http://www.TewMillion.com

Other active stocks are Vion Pharmaceuticals Inc. (NASDAQ: VION) and Quantum Fuel Systems Technologies Worldwide Inc. (NASDAQ: QTWW).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A Third Party has hired and paid $500.00 for the publication and circulation of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information